Literature DB >> 15802622

Extracellular proteases in atherosclerosis and restenosis.

Arturo Garcia-Touchard1, Timothy D Henry, Giuseppe Sangiorgi, Luigi Giusto Spagnoli, Alessandro Mauriello, Cheryl Conover, Robert S Schwartz.   

Abstract

Extracellular proteolysis plays a key role in many pathophysiologic processes including cancer, inflammatory diseases, and cardiovascular conditions such as atherosclerosis and restenosis. Whereas matrix metalloproteinases are their best known member, many others are becoming better known. The extracellular proteases are a complex and heterogeneous superfamily of enzymes. They include metalloproteinases (matrix metalloproteinases, adamalysins, or pappalysins), serine proteases (elastase, coagulation factors, plasmin, tissue plasminogen activator, urokinase plasminogen activator), and the cysteine proteases (such cathepsins). In addition to their matrix degradation capabilities, they have other less well known biologic functions that include angiogenesis, growth factor bioavailability, cytokine modulation, receptor shedding, enhancing cell migration, proliferation, invasion, and apoptosis. This review discusses extracellular proteases relevant to the vasculature, their classification and function, and how protease disorders contribute to arterial plaque growth, including chronic atherosclerosis, acute coronary syndromes, restenosis, and vascular remodeling. These broad extracellular protease functions make them potentially interesting therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802622     DOI: 10.1161/01.ATV.0000164311.48592.da

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  40 in total

Review 1.  Molecular imaging in cardiovascular disease: targets and opportunities.

Authors:  Stanley Y Shaw
Journal:  Nat Rev Cardiol       Date:  2009-07-21       Impact factor: 32.419

2.  Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis.

Authors:  Carine Savarin; Stephen A Stohlman; Roscoe Atkinson; Richard M Ransohoff; Cornelia C Bergmann
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

3.  Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases.

Authors:  Hideyuki Umeda; Masanori Aikawa; Peter Libby
Journal:  Biochem Biophys Res Commun       Date:  2011-06-25       Impact factor: 3.575

4.  Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties.

Authors:  Scott M Gordon; Benjamin McKenzie; Georgina Kemeh; Maureen Sampson; Shira Perl; Neal S Young; Michael B Fessler; Alan T Remaley
Journal:  Mol Cell Proteomics       Date:  2015-10-19       Impact factor: 5.911

5.  The effect of different protease inhibitors on stability of parathyroid hormone, insulin, and prolactin levels under different lag times and storage conditions until analysis.

Authors:  Ozgur Baykan; Ali Yaman; Fethullah Gerin; Onder Sirikci; Goncagul Haklar
Journal:  J Clin Lab Anal       Date:  2017-01-30       Impact factor: 2.352

Review 6.  Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.

Authors:  Vivian Hook; Lydiane Funkelstein; Jill Wegrzyn; Steven Bark; Mark Kindy; Gregory Hook
Journal:  Biochim Biophys Acta       Date:  2011-09-08

7.  Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis.

Authors:  Farouc A Jaffer; Claudio Vinegoni; Michael C John; Elena Aikawa; Herman K Gold; Aloke V Finn; Vasilis Ntziachristos; Peter Libby; Ralph Weissleder
Journal:  Circulation       Date:  2008-10-13       Impact factor: 29.690

Review 8.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

9.  The metalloprotease PrtV from Vibrio cholerae.

Authors:  Karolis Vaitkevicius; Pramod K Rompikuntal; Barbro Lindmark; Rimas Vaitkevicius; Tianyan Song; Sun N Wai
Journal:  FEBS J       Date:  2008-05-10       Impact factor: 5.542

10.  Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processes.

Authors:  Natasha Barascuk; Helene Skjøt-Arkil; Thomas C Register; Lise Larsen; Inger Byrjalsen; Claus Christiansen; Morten A Karsdal
Journal:  BMC Cardiovasc Disord       Date:  2010-04-21       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.